Developed regulatory documentation and quality systems.
Engaged stakeholders and generated evidence.
Provided freelance scientific support in microbiology, medical affairs, and life sciences communication.
Jan 2022 - Jun 2022
6 months
Lyon, France
Interim Manager of Microbiology Technological Unit
BIOASTER
Directed 20 FTEs, aligning microbiology and preclinical operations with strategic goals.
Led pharma collaborations to advance microbiology-based technologies toward commercialization.
Secured ISO 9001 accreditation through quality system optimization and regulatory readiness.
Jul 2021 - Aug 2024
3 years 2 months
Lyon, France
Evidence Generation Team Leader Microbiology
BIOASTER
Led cross-functional R&D teams in diagnostics, microbiota, and infectious diseases.
Managed collaborations with pharma, biotech, and research institutes.
Developed BIOFILM-ID (biofilm profiling toolkit) and centralized bacterial strain collection for industrial partnerships.
Co-developed AI-powered platforms (HoloMoA, MetSaMoA, BIND-IT) for antibiotic mode-of-action prediction and molecular profiling including early-stage VHH-discovery workflow.
Contributed to strategic development of VHH discovery workflows by integrating display technologies, NGS, and structural modeling.
Provided scientific input to internal decision-making and stakeholder communications.
Built strategic partnerships and drove co-development of microbiology solutions with external stakeholders.
Mentored 3 scientists and students, aligning execution with key R&D milestones.
Oversaw complex projects from concept to delivery under ISO 9001 and IVDR compliance.
Keynote speaker at ESVB 2021 on biofilm innovation and translational research.
Dec 2019 - Jun 2021
1 year 7 months
Lyon, France
Senior Scientist - Microbiologist
BIOASTER
Applied genomics and metabolomics to study mode-of-action of anti-biofilm compounds.
Developed novel assays for biofilm formation, inhibition, and eradication.
Restructured scientific teams for efficiency and specialization.
Authorized for BSL-3 high-containment pathogen research.
Mar 2017 - Nov 2019
2 years 9 months
Leiden, Netherlands
Medical Information Specialist
Janssen Biologics
Supported the immunology portfolio (Remicade®, Simponi®, Stelara®, Tremfya®) by providing accurate, compliant medical information.
Translated complex scientific and clinical data into clear, medically approved materials for healthcare professionals and patients.
Responded to medical inquiries and managed reporting of Adverse Events (AEs) and Product Quality Complaints (PQCs) in line with GMP and internal SOPs.
Contributed to cross-functional knowledge sharing and ensured alignment between medical, regulatory, and safety teams.
Aug 2013 - Jan 2016
2 years 6 months
Delft, Netherlands
Research Scientist | Lab Manager
TU Delft
Led single-molecule protein sequencing projects under GLP standards, focusing on recombinant and fluorescent-tagged proteins.
Purified and quantified biomolecules using HPLC-MS to study molecular mechanisms.
Established and managed the ML-1 insect lab and HPLC facility, boosting departmental R&D capacity.
Developed SOPs, ensured biosafety compliance, and upheld high operational standards.
Jun 2008 - Jun 2009
1 year 1 month
Ramat Gan, Israel
Research Assistant
Bar Ilan University
Designed an in vitro mRNA splicing model for Trypanosoma brucei, expanding RNA biology insights.
Conducted spliceosome analysis and radioisotope-based experimentation.
Co-supervised a Master’s student, supporting academic training.
Oct 2007 - May 2008
8 months
Warsaw, Poland
Microbiologist Consultant
Smith & Nephew
Delivered clinical training on ACTICOAT, an antimicrobial barrier dressing for wound care, promoting evidence-based use among healthcare providers.
Oct 2005 - Sep 2007
2 years
Kraków, Poland
Research Assistant
Jagiellonian University
Conducted genetic and biochemical analyses of extracellular bacterial proteases.
Delivered advanced microbiology instruction and supervised two Bachelor theses.
Summary
Innovative microbiologist with 15+ years of international experience spanning R&D project leadership in antimicrobial resistance, microbiota, diagnostics, and regulatory science, budget oversight, translating complex data into actionable insights.
Cross-functional collaboration and team development, key achievements include AI-integrated platforms for antibiotic mode-of-action prediction (HoloMoA, MetSaMoA), synthetic binder (VHH) development (Bind-IT), and microbial biofilm profiling (BIOFILM-ID).